Johnson & Johnson (JNJ.DE)

EUR 133.26

(-1.62%)

Net Income Summary of Johnson & Johnson

  • Johnson & Johnson's latest annual net income in 2023 was 35.15 Billion USD , up 95.94% from previous year.
  • Johnson & Johnson's latest quarterly net income in 2024 Q1 was 3.25 Billion USD , down -19.61% from previous quarter.
  • Johnson & Johnson reported an annual net income of 17.94 Billion USD in 2022, down -14.07% from previous year.
  • Johnson & Johnson reported an annual net income of 20.87 Billion USD in 2021, up 41.89% from previous year.
  • Johnson & Johnson reported a quarterly net income of 2.69 Billion USD for 2024 Q3, down -42.51% from previous quarter.
  • Johnson & Johnson reported a quarterly net income of 4.68 Billion USD for 2024 Q2, up 43.96% from previous quarter.

Annual Net Income Chart of Johnson & Johnson (2023 - 1989)

Historical Annual Net Income of Johnson & Johnson (2023 - 1989)

Year Net Income Net Income Growth
2023 35.15 Billion USD 95.94%
2022 17.94 Billion USD -14.07%
2021 20.87 Billion USD 41.89%
2020 14.71 Billion USD -2.68%
2019 15.11 Billion USD -1.16%
2018 15.29 Billion USD 1076.69%
2017 1.3 Billion USD -92.14%
2016 16.54 Billion USD 7.34%
2015 15.4 Billion USD -5.6%
2014 16.32 Billion USD 18.02%
2013 13.83 Billion USD 27.44%
2012 10.85 Billion USD 12.21%
2011 9.67 Billion USD -27.46%
2010 13.33 Billion USD 8.71%
2009 12.26 Billion USD -5.27%
2008 12.94 Billion USD 22.44%
2007 10.57 Billion USD -4.32%
2006 11.05 Billion USD 6.17%
2005 10.41 Billion USD 22.35%
2004 8.5 Billion USD 18.23%
2003 7.19 Billion USD 9.1%
2002 6.59 Billion USD 16.39%
2001 5.66 Billion USD 18.08%
2000 4.8 Billion USD 15.19%
1999 4.16 Billion USD 36.22%
1998 3.05 Billion USD -7.39%
1997 3.3 Billion USD 14.41%
1996 2.88 Billion USD 20.14%
1995 2.4 Billion USD 19.79%
1994 2 Billion USD 12.26%
1993 1.78 Billion USD 73.5%
1992 1.03 Billion USD -29.5%
1991 1.46 Billion USD 27.82%
1990 1.14 Billion USD 5.64%
1989 1.08 Billion USD 11.09%

Peer Net Income Comparison of Johnson & Johnson

Name Net Income Net Income Difference
Bayer Aktiengesellschaft -2.94 Billion EUR 1295.274%
Sanofi 5.4 Billion EUR -550.981%